Search Results - "Starling, N" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

by Papamichael, D., Audisio, R.A., Glimelius, B., de Gramont, A., Glynne-Jones, R., Haller, D., Köhne, C.-H., Rostoft, S., Lemmens, V., Mitry, E., Rutten, H., Sargent, D., Sastre, J., Seymour, M., Starling, N., Van Cutsem, E., Aapro, M.
Published in Annals of oncology (01.03.2015)

Get full text

Journal Article

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial

by Grenader, T., Waddell, T., Peckitt, C., Oates, J., Starling, N., Cunningham, D., Bridgewater, J.
Published in Annals of oncology (01.04.2016)

Get full text

Journal Article

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

by Tempero, M., Oh, D.-Y., Tabernero, J., Reni, M., Van Cutsem, E., Hendifar, A., Waldschmidt, D.-T., Starling, N., Bachet, J.-B., Chang, H.-M., Maurel, J., Garcia-Carbonero, R., Lonardi, S., Coussens, L.M., Fong, L., Tsao, L.C., Cole, G., James, D., Macarulla, T.
Published in Annals of oncology (01.05.2021)

Get full text

Journal Article

Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy

Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy

by R, Openshaw M, J, Williams, T, Foo, C, Moss, A, Wotherspoon, N, Starling, Z, Kemp
Published in Journal of gastrointestinal cancer (01.09.2023)

Get full text

Journal Article

Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends

Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends

by Edwards, P., Davidson, M., Calamai, V., Cunningham, D., Starling, N.
Published in Cancer treatment reviews (01.12.2018)

Get full text

Journal Article

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation combined modality therapy

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation combined modality therapy

by SULTANA, A, TUDUR SMITH, C, CUNNINGHAM, D, STARLING, N, TAIT, D, NEOPTOLEMOS, J. P, GHANEH, P
Published in British journal of cancer (23.04.2007)

Get full text

Journal Article

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study

by Rao, S., Starling, N., Cunningham, D., Sumpter, K., Gilligan, D., Ruhstaller, T., Valladares-Ayerbes, M., Wilke, H., Archer, C., Kurek, R., Beadman, C., Oates, J.
Published in Annals of oncology (01.11.2010)

Get full text

Journal Article

Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments

Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments

by Gordon, Anderley, Johnston, Edwina, Lau, David K, Starling, Naureen
Published in OncoTargets and therapy (01.01.2022)

Get full text

Journal Article

The use of first, second and beyond line chemotherapy for metastatic pancreatic ductal adenocarcinoma at the Royal Marsden Hospital

The use of first, second and beyond line chemotherapy for metastatic pancreatic ductal adenocarcinoma at the Royal Marsden Hospital

by Butters, O., Swann, F., Leslie, I., Young, K., Kouvelakis, K., Watkins, D., Rao, S., Chau, I., Cunningham, D., Starling, N.
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG) cancer: A pooled analysis of four randomised trials

Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG) cancer: A pooled analysis of four randomised trials

by Davidson, M., Wagner, A.D., Kouvelakis, K., Starling, N., Chau, I., Watkins, D., Rao, S., Peckitt, C., Cunningham, D.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

Cost-effectiveness analysis of cetuximab irinotecan vs active best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment

Cost-effectiveness analysis of cetuximab irinotecan vs active best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment

by STARLING, N, TILDEN, D, WHITE, J, CUNNINGHAM, D
Published in British journal of cancer (29.01.2007)

Get full text

Journal Article

Treatment of relapsed oesophagogastric adenocarcinoma after perioperative chemotherapy and surgery

Treatment of relapsed oesophagogastric adenocarcinoma after perioperative chemotherapy and surgery

by Davidson, M., Butler, C., Butters, O., Fong, C., Turkes, F., Cafferkey, C., Kouvelakis, K., Cunningham, D., Watkins, D., Rao, S., Starling, N., Chau, I.
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses

by SULTANA, A, TUDUR SMITH, C, CUNNINGHAM, D, STARLING, N, NEOPTOLEMOS, J. P, GHANEH, P
Published in British journal of cancer (08.07.2008)

Get full text

Journal Article

Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study

Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study

by Tempero, M., Oh, D., Macarulla, T., Reni, M., Van Cutsem, E., Hendifar, A., Waldschmidt, D., Starling, N., Bachet, J., Chang, H., Maurel, J., Lonardi, S., Coussens, L., Fong, L., Tsao, L., Cole, G., James, D., Tabernero, J.
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service

Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service

by Lidington, E., Darlington, A.S., Vlooswijk, C., Beardsworth, S., McCaffrey, S., Tang, S., Stallard, K., Younger, E., Edwards, P., Ali, A.I., Nandhabalan, M., Din, A., Starling, N., Larkin, J., Stanway, S., Nobbenhuis, M., Banerjee, S., Szucs, Z., Gonzalez, M., Sirohi, B., Husson, O., van der Graaf, W.T.A.
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.08.2021)

Get full text

Journal Article

Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy

Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy

by Davidson, M., Nankivell, M., Cunningham, D., Starling, N., Koh, D.-M., Brown, G., Allum, W., Wotherspoon, A., Smyth, E., Ly, L., Kleovoulou, N., Langley, R., Riddell, A.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

by Moorcraft, S.Y., Gonzalez de Castro, D., Cunningham, D., Jones, T., Walker, B.A., Peckitt, C., Yuan, L.C., Frampton, M., Begum, R., Eltahir, Z., Wotherspoon, A., Teixeira Mendes, L.S., Hulkki Wilson, S., Gillbanks, A., Baratelli, C., Fotiadis, N., Patel, A., Braconi, C., Valeri, N., Gerlinger, M., Rao, S., Watkins, D., Chau, I., Starling, N.
Published in Annals of oncology (01.01.2018)

Get full text

Journal Article

Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer

Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer

by Khakoo, S., Carter, P., Valeri, N., Shaikh, R., Jones, T., Begum, R., Rana, I., Picchia, S., Bali, M., Brown, G., Wotherspoon, A., Terlizzo, M., von Loga, K., Ahmed, I., Watkins, D., Chau, I., Starling, N., Tait, D., Hubank, M., Cunningham, D.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

ACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma

ACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma

by Harrison Palmer, D., Ross, P.J., Silcocks, P., Greenhalf, W., Faluyi, O., Ma, Y.T., Wadsley, J., Rawcliffe, C., Neoptolemos, J., Valle, J.W., Wasan, H., Starling, N., Patel, K., Bridgewater, J.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study

The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study

by Watkins, D.J, Starling, N, Cunningham, D, Thomas, J, Webb, J, Brown, G, Barbachano, Y, Oates, J, Chau, I
Published in European journal of cancer (1990) (01.05.2014)

Get full text

Journal Article

1
2
3
4
5
6
7
Next
[7]